| Literature DB >> 20132811 |
Li-Zhen Yang1, Philip Tovote, Martin Rayner, Jens Kockskämper, Burkert Pieske, Joachim Spiess.
Abstract
Corticotropin-releasing factor (CRF), a 41 amino acid peptide, was discovered as a key signal in mediating neuroendocrine, autonomic, and behavioral responses to stress. It was revealed later that there exist additional CRF-like peptides, termed urocortins. The CRF receptor subtype 1 (CRF1 receptor) is predominant in the brain whereas subtype 2 (CRF2 receptor) is highly expressed in the brain and the heart. Both centrally and peripherally administered CRF and urocortins produce significant hemodynamic effects via activation of CRF receptors in the brain and the heart. CRF and urocortins are important neural and cardioactive hormones, and are potentially useful therapy for heart failure. Published by Elsevier B.V.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20132811 DOI: 10.1016/j.ejphar.2010.01.027
Source DB: PubMed Journal: Eur J Pharmacol ISSN: 0014-2999 Impact factor: 4.432